NKTX

Nadir Mahmood

Known title: See RemarksCIK: 0001816598

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

Nkarta Sets 2026 Data Reveal as CAR NK Trials Progress. Nkarta announced that it is targeting a data reveal for its outpatient CAR NK trials in 2026. The company said the trials are advancing, indicating progress toward a potential regulatory milestone. This development may influence how the market views the company’s future prospects. The stock is currently trading near its support level of $2.61.

this person other insiders at NKTX

Transaction History

NKTX▼ Sell$12K
NKTX▲ Buy$0
NKTX▲ Buy$0
NKTX▼ Sell$3K
NKTX▼ Sell$6K
NKTX▲ Buy$0
NKTX▲ Buy$29K
NKTX▼ Sell$135K
NKTX▲ Buy$29K
NKTX▼ Sell$115K
NKTX▼ Sell$100K
NKTX▲ Buy$29K
NKTX▲ Buy$0
NKTX▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.